bleuacacia (BLEU) 10-Q 11 Aug 23 2023 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2023	Aug. 11, 2023
Entity Listings [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2023
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Document Transition Report	false
Entity File Number	001-41074
Entity Registrant Name	bleuacacia ltd
Entity Central Index Key	0001843370
Entity Incorporation, State or Country Code	E9
Entity Tax Identification Number	98-1582905
Entity Address, Address Line One	500 Fifth Avenue
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10110
City Area Code	212
Local Phone Number	935- 5599
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Units [Member]
Entity Listings [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A ordinary share, one right and one-half of one redeemable warrant
Trading Symbol	BLEUU
Security Exchange Name	NASDAQ
Class A Ordinary Shares [Member]
Entity Listings [Line Items]
Title of 12(b) Security	Class A ordinary shares, $0.0001 par value per share
Trading Symbol	BLEU
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		1,584,019
Rights [Member]
Entity Listings [Line Items]
Title of 12(b) Security	Rights to acquire one-sixteenth of one Class A ordinary share
Trading Symbol	BLEUR
Security Exchange Name	NASDAQ
Redeemable Warrants [Member]
Entity Listings [Line Items]
Title of 12(b) Security	Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
Trading Symbol	BLEUW
Security Exchange Name	NASDAQ
Class B Ordinary Shares [Member]
Entity Listings [Line Items]
Entity Common Stock, Shares Outstanding		6,900,000

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Cash	$ 32,548	$ 60,591
Prepaid expenses	166,306	284,431
Total current assets	198,854	345,022
Investments held in Trust Account	16,579,323	279,359,521
Total Assets	16,778,177	279,704,543
Current liabilities:
Accounts payable	244,193	250,249
Accrued expenses	74,697	6,187
Total current liabilities	318,890	256,436
Convertible working capital loan - related party	$ 774,480	$ 300,000
Notes Payable, Noncurrent, Related Party, Type [Extensible Enumeration]	Sponsor [Member]	Sponsor [Member]
Deferred underwriting commissions	$ 9,660,000	$ 9,660,000
Total Liabilities	10,753,370	10,216,436
Commitments and Contingencies (Note 6)
Shareholders' Deficit:
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding	0	0
Additional paid-in capital	0	0
Accumulated deficit	(10,455,206)	(9,772,104)
Total shareholders' deficit	(10,454,516)	(9,771,414)
Liabilities, Class A ordinary Shares Subject to Redemption, and Shareholders' Deficit	16,778,177	279,704,543
Class A Ordinary Shares [Member]
Current liabilities:
Class A ordinary shares subject to possible redemption; $0.0001 par value; 1,584,019 and 27,600,000 shares at redemption value of approximately $10.36 and $10.12 per share as of June 30, 2023 and December 31, 2022, respectively	16,479,323	279,259,521
Shareholders' Deficit:
Common shares - $0.0001 par value	0	0
Class B Ordinary Shares [Member]
Shareholders' Deficit:
Common shares - $0.0001 par value	$ 690	$ 690

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2023	May 17, 2023	Dec. 31, 2022
Shareholders' Deficit:
Preference shares, par value (in dollars per share)	$ 0.0001		$ 0.0001
Preference shares, shares authorized (in shares)	5,000,000		5,000,000
Preference shares, shares issued (in shares)	0		0
Preference shares, shares outstanding (in shares)	0		0
Class A Ordinary Shares [Member]
Liabilities, Class A Ordinary Shares Subject to Redemption, and Shareholders' Deficit
Ordinary shares subject to possible redemption, par value (in dollars per share)	$ 0.0001		$ 0.0001
Ordinary shares subject to possible redemption (in shares)	1,584,019		27,600,000
Ordinary shares subject to possible redemption, redemption price (in dollars per share)	$ 10.4	$ 10.29	$ 10.12
Shareholders' Deficit:
Ordinary shares, par value (in dollars per share)	$ 0.0001		$ 0.0001
Ordinary shares,, shares authorized (in shares)	500,000,000		500,000,000
Ordinary shares, shares issued (in shares)	0		0
Ordinary shares, shares outstanding (in shares)	0		0
Class B Ordinary Shares [Member]
Shareholders' Deficit:
Ordinary shares, par value (in dollars per share)	$ 0.0001		$ 0.0001
Ordinary shares,, shares authorized (in shares)	50,000,000		50,000,000
Ordinary shares, shares issued (in shares)	6,900,000		6,900,000
Ordinary shares, shares outstanding (in shares)	6,900,000		6,900,000

UNAUDITED CONDENSED STATEMENTS

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Loss from operations:
Loss from operations	$ (435,129)	$ (201,073)	$ (683,102)	$ (503,222)
Other income:
Gain (Loss) from investments held in Trust Account	1,901,202	(111,540)	4,973,303	(129,719)
Net income (loss)	1,466,073	(312,613)	4,290,201	(632,941)
Related Party [Member]
Loss from operations:
General and administrative expenses	30,000	30,000	60,000	60,334
Nonrelated Party [Member]
Loss from operations:
General and administrative expenses	$ 405,129	$ 171,073	$ 623,102	$ 442,888
Class A Ordinary Shares [Member]
Other income:
Weighted average number of ordinary shares outstanding, basic (in shares)	16,450,307	27,600,000	21,994,353	27,600,000
Basic net income (loss) per share (in dollars per share)	$ 0.06	$ (0.01)	$ 0.15	$ (0.02)
Weighted average number of ordinary shares outstanding, diluted (in shares)	16,450,307	27,600,000	21,994,353	27,600,000
Diluted net income (loss) per share (in dollars per share)	$ 0.06	$ (0.01)	$ 0.15	$ (0.02)
Class B Ordinary Shares [Member]
Other income:
Weighted average number of ordinary shares outstanding, basic (in shares)	6,900,000	6,900,000	6,900,000	6,900,000
Basic net income (loss) per share (in dollars per share)	$ 0.06	$ (0.01)	$ 0.15	$ (0.02)
Weighted average number of ordinary shares outstanding, diluted (in shares)	6,900,000	6,900,000	6,900,000	6,900,000
Diluted net income (loss) per share (in dollars per share)	$ 0.06	$ (0.01)	$ 0.15	$ (0.02)

UNAUDITED CONDENSED STATEMENT_2

UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT - USD ($)	Ordinary Shares [Member] Class A Ordinary Shares [Member]	Ordinary Shares [Member] Class B Ordinary Shares [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Beginning balance at Dec. 31, 2021	$ 0	$ 690	$ 0	$ (9,018,034)	$ (9,017,344)
Beginning balance (in shares) at Dec. 31, 2021	0	6,900,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ 0	$ 0	0	(320,329)	(320,329)
Ending balance at Mar. 31, 2022	$ 0	$ 690	0	(9,338,363)	(9,337,673)
Ending balance (in shares) at Mar. 31, 2022	0	6,900,000
Beginning balance at Dec. 31, 2021	$ 0	$ 690	0	(9,018,034)	(9,017,344)
Beginning balance (in shares) at Dec. 31, 2021	0	6,900,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)					(632,941)
Contribution - shareholder non-redemption agreements					0
Ending balance at Jun. 30, 2022	$ 0	$ 690	0	(9,650,976)	(9,650,286)
Ending balance (in shares) at Jun. 30, 2022		6,900,000
Beginning balance at Mar. 31, 2022	$ 0	$ 690	0	(9,338,363)	(9,337,673)
Beginning balance (in shares) at Mar. 31, 2022	0	6,900,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ 0	$ 0	0	(312,613)	(312,613)
Ending balance at Jun. 30, 2022	0	$ 690	0	(9,650,976)	(9,650,286)
Ending balance (in shares) at Jun. 30, 2022		6,900,000
Beginning balance at Dec. 31, 2022	$ 0	$ 690	0	(9,772,104)	(9,771,414)
Beginning balance (in shares) at Dec. 31, 2022	0	6,900,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ 0	$ 0	0	2,824,128	2,824,128
Remeasurement on Class A common stock subject to possible redemption	0	0	0	(3,072,101)	(3,072,101)
Ending balance at Mar. 31, 2023	$ 0	$ 690	0	(10,020,077)	(10,019,387)
Ending balance (in shares) at Mar. 31, 2023	0	6,900,000
Beginning balance at Dec. 31, 2022	$ 0	$ 690	0	(9,772,104)	(9,771,414)
Beginning balance (in shares) at Dec. 31, 2022	0	6,900,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)					4,290,201
Contribution - shareholder non-redemption agreements					363,750
Ending balance at Jun. 30, 2023	$ 0	$ 690	0	(10,455,206)	(10,454,516)
Ending balance (in shares) at Jun. 30, 2023	0	6,900,000
Beginning balance at Mar. 31, 2023	$ 0	$ 690	0	(10,020,077)	(10,019,387)
Beginning balance (in shares) at Mar. 31, 2023	0	6,900,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ 0	$ 0	0	1,466,073	1,466,073
Contribution - shareholder non-redemption agreements	0	0	363,750	0	363,750
Shareholder non-redemption agreements	0	0	(363,750)	0	(363,750)
Remeasurement on Class A common stock subject to possible redemption	0	0	0	(1,901,202)	(1,901,202)
Ending balance at Jun. 30, 2023	$ 0	$ 690	$ 0	$ (10,455,206)	$ (10,454,516)
Ending balance (in shares) at Jun. 30, 2023	0	6,900,000

UNAUDITED CONDENSED STATEMENT_3

UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2022
Cash Flows from Operating Activities:
Net income (loss)	$ 1,466,073	$ 4,290,201	$ (632,941)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
(Gain) Loss from investments held in the Trust Account	(1,901,202)	(4,973,303)	129,719
Changes in operating assets and liabilities:
Prepaid expenses		118,125	146,479
Accounts payable		(6,056)	204,541
Accrued expenses		68,510	1,359
Net cash used in operating activities		(502,523)	(150,843)
Cash Flows from Investing Activities:
Cash withdrawn from trust account in connection with redemption		267,753,501	0
Net cash provided by investing activities		267,753,501	0
Cash Flows from Financing Activities:
Proceeds from convertible working capital loan		474,480	0
Redemption of ordinary shares		(267,753,501)	0
Net cash used in financing activities		(267,279,021)	0
Net change in cash		(28,043)	(150,843)
Cash - beginning of the period		60,591	155,238
Cash - end of the period	32,548	32,548	4,395
Supplemental disclosure of non-cash investing and financing activities:
Remeasurement on Class A ordinary shares subject to possible redemption		4,973,303	0
Contribution - shareholder non-redemption agreements	$ 363,750	$ 363,750	$ 0

DESCRIPTION OF ORGANIZATION AND

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	6 Months Ended
	Jun. 30, 2023
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS [Abstract]
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1. - D ESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS bleuacacia ltd (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on February 11, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses that the Company has not yet identified (“Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus its search on a premium branded consumer retail business. As of June 30, 2023, the Company had not yet commenced operations. All activity for the period from February 11, 2021 (inception) through June 30, 2023 relates to the Company’s formation and the Initial Public Offering (as defined below), and, since the closing of the Initial Public Offering, the search for and efforts toward completing an initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end. The Company’s sponsor is bleuacacia sponsor LLC, a Cayman Islands limited liability company (“Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on November 17, 2021. On November 22, 2021, the Company consummated its Initial Public Offering of 27,600,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), including the issuance of 3,600,000 Units as a result of the underwriters’ full exercise of their over-allotment option, at $10.00 per Unit, generating gross proceeds of $276.0 million, and incurring offering costs of approximately $16.3 million, of which approximately $9.7 million was for deferred underwriting commissions (Note 6). Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 7,520,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant to the Sponsor, generating proceeds of approximately $7.5 million (Note 4). Upon the closing of the Initial Public Offering and the Private Placement, $276.0 million ($10.00 per Unit) of net proceeds, including the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement, was placed in a trust account (“Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee and invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, or the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding any deferred underwriters fees and taxes payable on the income earned on the Trust Account) at the time the Company signs a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide its holders of the Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially at $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share). The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares are classified as temporary equity in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity” (“ASC 480”). In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) have agreed to vote their Founder Shares (as defined below in Note 4) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. Subsequent to the consummation of the Initial Public Offering, the Company adopted an insider trading policy which requires insiders to: (i) refrain from purchasing shares during certain blackout periods and when they are in possession of any material non-public information and (ii) to clear all trades with the Company’s Executive Director (or his or her designee) prior to execution. In addition, the initial shareholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the holders of the Founder Shares (as defined in Note 5) prior to the Initial Public Offering (the “Initial Shareholders”) agreed to vote their Founder Shares and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Initial Shareholders agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. Notwithstanding the foregoing, the Company’s Amended and Restated Memorandum and Articles of Association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. The Company’s Sponsor, executive officers and directors agreed not to propose an amendment to the Company’s Amended and Restated Memorandum and Articles of Association that would affect the substance or timing of the Company’s obligation to provide for the redemption of its Public Shares in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment. On May 19, 2023, the Company held an extraordinary general meeting of shareholders (the “Extension Meeting”) at which its shareholders approved proposals to amend the Company’s Amended and Restated Memorandum and Articles of Association to (i) extend the date (the “Termination Date”) by which the Company must consummate its initial Business Combination from May 22, 2023 to August 22, 2023 (the “Articles Extension Date”) and to allow the Company, without another shareholder vote, to elect to extend the Termination Date to consummate a Business Combination on a monthly basis for up to six times by an additional one month each time after the Articles Extension Date, by resolution of the board of directors, if requested by the Sponsor, and upon five days’ advance notice prior to the applicable Termination Date, until February 22, 2024, or a total of up to nine months after May 22, 2023, unless the closing of a Business Combination shall have occurred prior thereto (the “Extension”) and (ii) eliminate from the Company’s Amended and Restated Memorandum and Articles of Association the redemption limitation that the Company may not redeem Public Shares to the extent that such redemption would result in the Company having net tangible assets of less than $5,000,001. If the Company is unable to complete a Business Combination before August 22, 2023, or such later date to which the Termination Date may be extended (but no later than February 22, 2024), or during any extended time (the “Extension Period”) that the Company has to consummate a business combination as a result of a shareholder vote to amend the Amended and Restated Memorandum and Articles of Association (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten In connection with the redemption of 100% of the Company’s outstanding Public Shares for a portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company’s taxes payable (less up to $100,000 of interest to pay dissolution expenses). The Initial Shareholders agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company’s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable; provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Liquidity and Going Concern As of June 30, 2023, the Company had approximately $33,000 in cash, a working capital deficit of approximately $120,000 and the ability to borrow up to an aggregate of approximately remaining The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor to cover certain expenses on behalf of the Company in exchange for issuance of Founder Shares (as defined in Note 5), and loan proceeds from the Sponsor of approximately $167,000 under the 2021 Note (as defined in Note 5). The Company partially repaid approximately $166,000 owed under the 2021 Note upon closing of the Initial Public Offering and repaid the remaining balance of approximately $1,000 on November 24, 2021. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity needs have been satisfied through the net proceeds from the consummation of the Initial Public Offering, the Private Placement held outside of the Trust Account and from borrowing under the 2022 Note. On April 1, 2022, the Company entered into a convertible promissory note (the “2022 Note”) Pursuant to the 2022 Note, the Company may borrow from the Sponsor, from time to time Borrowings under the 2022 Note will not bear interest. The 2022 Note will mature on the earlier to occur of (i) 18 months from the closing of the Initial Public Offering (or up to any Extension Period, if applicable) or (ii) the effective date of the Company’s initial business combination. Up to $1,500,000 of such loans may be converted into Private Placement Warrants of the post-business combination entity at a price of $1.00 per warrant at the option of the Sponsor. The 2022 Note contains customary events of default, including those relating to the Company’s failure to repay the principal amount due upon maturity of the 2022 Note and certain bankruptcy events. In March 2023 and July 2022, the Company borrowed approximately $474,000 and , respectively approximately $774,000 and outstanding In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements – Going Concern,” management of the Company has determined that the liquidity issue, mandatory liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after August 22, 2023. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these financial statements.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2. - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and Article 8 of Regulation S-X. Accordingly, certain disclosures included in the annual financial statements have been condensed or omitted from these financial statements as they are not required for interim financial statements . In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and six months ended June 30, 2023 are not necessarily The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC on April 5, 2023, which contains the audited financial statements and notes thereto. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies. The Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of condensed financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ from those estimates. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. As of June 30, 2023 and December 31, 2022, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of June 30, 2023 and December 31, 2022. Investments Held in the Trust Account The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in net gain from investments held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements,” approximates the carrying amounts represented in the balance sheets, primarily due to their short-term nature. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Derivative Financial Instruments The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company accounted for its Rights (as defined below) as equity-classified instruments based on an assessment of the Rights’ specific terms and applicable authoritative guidance in ASC 480 and ASC 815. The assessment considered whether the Rights were freestanding financial instruments pursuant to ASC 480, met the definition of a liability pursuant to ASC 480, and whether the Rights met all the requirements for equity classification under ASC 815, including whether the Rights were indexed to the Company’s own ordinary shares, among other conditions for the equity classification. The warrants issued in connection with its Initial Public Offering (the “Public Warrants”) and Private Placement Warrants are classified in accordance with ASC 480 and ASC 815, which provides that the warrants are not precluded from equity classification. Equity-classified contracts were initially measured at fair value (or allocated value). Subsequent changes in fair value will not be recognized as long as the contracts continue to be classified in equity in accordance with ASC 480 and ASC 815. Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with Public Warrants are recognized net in equity. Offering costs associated with the Class A ordinary shares were charged against the carrying value of Class A ordinary shares upon the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. Class A Ordinary Shares Subject to Possible Redemption Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, all outstanding Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets. Under ASC 480, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the Initial Public Offering, the Company recognized the remeasurement from initial book value to redemption amount value. The change in the carrying value of the redeemable Class A ordinary shares resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit. Net Income (Loss) per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is calculated by dividing the net income (loss) by the weighted average shares of ordinary shares outstanding for the respective period. The calculation of diluted net income (loss) per ordinary shares does not consider the effect of the Public Warrants, the Private Placement Warrants and the Rights to purchase an aggregate of 23,045,000 Class A ordinary shares since their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and six months ended June 30, 2023 and 2022. The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of ordinary shares: For the Three Months Ended June 30, For the Six Months Ended June 30, 2023 2022 2023 2022 Class A Class B Class A Class B Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share Numerator: Allocation of net income (loss) $ 1,032,849 $ 433,224 $ (250,091 ) $ (62,523 ) $ 3,265,697 $ 1,024,504 $ (506,353 ) $ (126,588 ) Denominator: Basic and diluted weighted average ordinary shares outstanding 16,450,307 6,900,000 27,600,000 6,900,000 21,994,353 6,900,000 27,600,000 6,900,000 Basic and diluted net income (loss) per ordinary share $ 0.06 $ 0.06 $ (0.01 ) $ (0.01 ) $ 0.15 $ 0.15 $ (0.02 ) $ (0.02 ) Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Recent Accounting Standards In June 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-13 – Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13” Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

INITIAL PUBLIC OFFERING

INITIAL PUBLIC OFFERING	6 Months Ended
	Jun. 30, 2023
INITIAL PUBLIC OFFERING [Abstract]
INITIAL PUBLIC OFFERING	NOTE 3. - INITIAL PUBLIC OFFERIN On November 22, 2021, the Company consummated its Initial Public Offering of 27,600,000 Units, including the issuance of 3,600,000 Units as a result of the underwriters’ full exercise of their over-allotment option, at $10.00 per Unit, generating gross proceeds of $276.0 million, and incurring offering costs of approximately $16.3 million, of which approximately $9.7 million was for deferred underwriting commissions. Each Unit consists of one Class A ordinary share, one-half one-sixteenth

PRIVATE PLACEMENT

PRIVATE PLACEMENT	6 Months Ended
	Jun. 30, 2023
PRIVATE PLACEMENT [Abstract]
PRIVATE PLACEMENT	NOTE 4. - PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 7,520,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant to the Sponsor, generating proceeds of approximately $7.5 million. Each whole Private Placement Warrant is exercisable for one Class A ordinary share at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable for cash and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees. The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	Jun. 30, 2023
RELATED PARTY TRANSACTIONS [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 5. - RELATED PARTY TRANSACTIONS Founder Shares On February 12, 2021, the Company issued 8,625,000 Class B ordinary shares to the Sponsor (the “Founder Shares”) in exchange for the payment of $25,000 of the Company’s offering expenses. Founder Shares and the associated amounts reflect: (i) the surrender of 2,875,000 Class B ordinary shares to the Company at no consideration on October 25, 2021; and (ii) the share capitalization of Class B ordinary shares on November 17, 2021; resulting in a decrease in the total number of Class B ordinary shares outstanding to 6,900,000 Class B ordinary shares. The holders of the Founder Shares agreed to forfeit and cancel up to an aggregate of 900,000 Founder Shares, on a pro rata basis, to the extent that the option to purchase additional Units was not exercised in full by the underwriters, so that the Founder Shares would represent approximately 20% of the Company’s issued and outstanding shares after the Initial Public Offering. On November 22, 2021, the underwriters consummated the exercise in full of the over-allotment; thus, these 900,000 Founder Shares were no longer subject to forfeiture. The Sponsor agreed that upon and subject to the completion of the initial Business Combination, 25% of the Founder Shares then held by the Sponsor shall be considered to be newly unvested shares, one-half one-half In May 2021, the Sponsor transferred 40,000 Founder Shares to each of the two independent director nominees. The transfer of the Founder Shares is in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The Founder Shares were granted subject to a performance condition (i.e., the occurrence of a Business Combination). Compensation expense related to the Founder Shares is recognized only when the performance condition is probable of occurrence under the applicable accounting literature in this circumstance. As of June 30, 2023, the Company determined that a Business Combination is not considered probable, and, therefore, no stock-based compensation expense has been recognized. Stock-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon completion of a Business Combination) in an amount equal to the number of Founder Shares that ultimately vest multiplied times the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the Founder Shares. The Initial Shareholders agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their ordinary shares for cash, securities or other property. Related Party Loans The Sponsor agreed to loan the Company up to $300,000 pursuant to a promissory note, dated February 12, 2021, which was later amended and restated on July 30, 2021 (the “2021 Note”). In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor, members of the Company’s management team or any of their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be converted into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. On April 1, 2022, the Company entered into a convertible promissory note (the “2022 Note”) with the Sponsor, a related party of the Company. Pursuant to the 2022 Note the Company may borrow from the Sponsor, from time to time, up to an aggregate of Borrowings under the 2022 Note do not bear interest. The 2022 Note will mature on the earlier to occur of from the closing of the Initial Public Offering (or up to any Extension Period, if applicable) or (ii) the effective date of the Company’s initial Business Combination. If the Company completes a Business Combination, the Company will repay the 2022 Note out of the proceeds of the Trust Account released to the Company. Otherwise, the 2022 Loan will be repaid only out of funds held outside the Trust Account. Up to of such loans may be converted into Private Placement Warrants of the post-Business Combination entity at a price of per warrant at the option of the Sponsor. The 2022 Note contains customary events of default, including those relating to the Company’s failure to repay the principal amount due upon maturity of the 2022 Note and certain bankruptcy events. $474,000 under the 2022 Note, respectively. outstanding under the 2022 Note, respectively. Administrative Services Agreement On November 17, 2021, the Company agreed to pay an affiliate of the Sponsor $ 10,000 30,000 60,000 For the three and six months ended June 30, 2022, the Company incurred expenses of $ and $ , respectively, under this agreement. 5,000 5,000 In addition, the Sponsor, officers and directors, or their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company’s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. The Company’s audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, executive officers or directors, or their affiliates. Any such payments prior to an initial Business Combination will be made using funds held outside the Trust Account.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Jun. 30, 2023
COMMITMENTS AND CONTINGENCIES [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 6. - COMMITMENTS AND CONTINGENCIES Registration Rights The holders of the Founder Shares, Private Placement Warrants, and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) were entitled to registration rights pursuant to a registration rights agreement dated November 17, 2021 requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Class A ordinary shares). The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day option from November 17, 2021 to purchase up to 3,600,000 additional Units at the Initial Public Offering price less the underwriting discounts and commissions. On November 22, 2021, the underwriters consummated the exercise in full of the over-allotment option. The underwriters were entitled to an underwriting discount of $0.20 per unit, or approximately $5.5 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or approximately $9.7 million in the aggregate, will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Non-Redemption Agreement In May 2023, the Company and the Sponsor entered into non-redemption agreements (the “Non-Redemption Agreements”) with ten unaffiliated third parties (the “Non-Redeeming Shareholders”), pursuant to which such Non-Redeeming Shareholders agreed not to redeem (or to validly rescind any redemption requests with respect to) a portion of their ordinary shares of the Company, in an aggregate amount equal to 1,500,000 ordinary shares (the “Non-Redeemed Shares”) in connection with the Extension Meeting held on May 19, 2023, but such Non-Redeeming Shareholders retained their right to require the Company to redeem such Non-Redeemed Shares in connection with the closing of the Business Combination. In exchange for the foregoing commitment, the Sponsor agreed to transfer to such Non-Redeeming Shareholders an aggregate of 375,000 Founder Shares held by the Sponsor immediately following the consummation of an initial Business Combination. The Company estimated the aggregate fair value of such 375,000 Founder Shares transferrable to the Non-Redeeming Shareholders pursuant to the Non-Redemption Agreements to be $363,750 or approximately $0.97 per share. The fair value was determined using the probability of a successful Business Combination of 9.98%, a volatility of 26.2%, a discount for lack of marketability of 6.5%, and the average value per share as of the valuation date of $10.42 derived from an option pricing model for publicly traded warrants. Each Non-Redeeming Shareholder acquired from the Sponsor an indirect economic interest in such Founder Shares. The excess of the fair value of such Founder Shares was determined to be an offering cost in accordance with Staff Accounting Bulletin Topic 5A. Accordingly, in substance, it was recognized by the Company as a capital contribution by the Sponsor to induce the Non-Redeeming Shareholders not to redeem the Non-Redeemed Shares, with a corresponding charge to additional paid-in capital to recognize the fair value of the Founder Shares subject to transfer as an offering cost.

CLASS A ORDINARY SHARES SUBJECT

CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION	6 Months Ended
	Jun. 30, 2023
CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION [Abstract]
CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION	NOTE 7. - CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION The Company’s Class A ordinary shares contain certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 500,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of June 30, 2023 and December 31, 2022, there were 1,584,019 and 27,600,000 Class A ordinary shares The Class A ordinary shares subject to possible redemption are reflected in the following table: Gross proceeds $ 276,000,000 Less: Proceeds allocated to Public Warrants and Rights (7,624,500 ) Class A ordinary shares issuance costs (15,877,541 ) Plus: Adjust carrying value to initial redemption value 26,761,562 Class A ordinary shares subject to possible redemption, December 31, 2022 279,259,521 Plus: Remeasurement on Class A ordinary shares subject to possible redemption 3,072,101 Class A ordinary shares subject to possible redemption, March 31, 2023 282,331,622 Less: Redemptions (267,753,501 ) Plus: Remeasurement on Class A ordinary shares subject to possible redemption 1,901,202 Class A ordinary shares subject to possible redemption, June 30, 2023 $ 16,479,323

SHAREHOLDERS' DEFICIT

SHAREHOLDERS' DEFICIT	6 Months Ended
	Jun. 30, 2023
SHAREHOLDERS' DEFICIT [Abstract]
SHAREHOLDERS' DEFICIT	NOTE 8. - SHAREHOLDERS’ DEFICIT Preference Shares The Company is authorized to issue 5,000,000 preference shares with a par value of $0.0001 per share. As of June 30, 2023 and December 31, 2022, there were no preference shares issued or outstanding. Class A Ordinary Shares The Company is authorized to issue 500,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of June 30, 2023 and December 31, 2022, there were 1,584,019 and 27,600,000 Class A ordinary shares Class B Ordinary Shares The Company is authorized to issue 50,000,000 Class B ordinary shares with a par value of $0.0001 per share. As of June 30, 2023 and December 31, 2022, there were 6,900,000 Class B ordinary shares issued and outstanding. The holders of the Founder Shares agreed to forfeit and cancel up to an aggregate of 900,000 Class B ordinary shares for no consideration to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the Initial Shareholders would collectively own 20% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering. On November 22, 2021, the underwriters consummated the exercise in full of the over-allotment option; thus, these 900,000 Class B ordinary shares were no longer subject forfeiture. Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the shareholders except as required by law. The Class B ordinary shares will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation of the initial Business Combination on a one-for-one basis, subject to adjustment for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, 20% of the total number of ordinary shares outstanding after such conversion, including the total number of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in the initial Business Combination, any private placement warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis. Rights As of June 30, 2023 and December 31, 2022, the Company had 27,587,477 and 27,600,000 Rights outstanding, respectively. Each holder of a right will receive one-sixteenth one-sixteenth Warrants As of June 30, 2023 and December 31, 2022, the Company had 13,800,000 Public Warrants and 7,520,000 Private Placement Warrants outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business Combination. The Company agreed that as soon as practicable, but in no event later than 20 business days after the closing of the initial Business Combination, the Company will use commercially reasonable efforts to file with the SEC and have an effective registration statement covering the Class A ordinary shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the public warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the th day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price of less than $9.20 per Class A ordinary share (with such issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Initial Shareholders or their affiliates, without taking into account any Founder Shares held by the Initial Shareholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and in the case of Public Warrants only, the $18.00 per share redemption trigger prices described under “Redemption of Public Warrants” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be non-redeemable and may be exercised on a cashless basis at the option of the holder. Redemption of Public Warrants Once the Public Warrants become exercisable, the Company may redeem the outstanding Public Warrants: • in whole and not in part; at a price of $0.01 per Public Warrant; • upon a minimum of 30 days’ prior written notice of redemption; • and if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 10 trading days within a 20-trading day period ending on the third The Company will not redeem the warrants for cash as described above unless a registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption period. If and when the Public Warrants become redeemable by the Company, it may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws. In no event will the public warrants be exercisable in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment). If the Company calls the Public Warrants for redemption for cash, as described above, the management will have the option to require all holders that wish to exercise Public Warrants to do so on a “cashless basis.” In determining whether to require all holders to exercise their Public Warrants on a “cashless basis,” the management will consider, among other factors, the Company’s cash position, the number of Public Warrants that are outstanding and the dilutive effect on the shareholders of issuing the maximum number of Class A ordinary shares issuable upon the exercise of the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

FAIR MARKET MEASUREMENTS

FAIR MARKET MEASUREMENTS	6 Months Ended
	Jun. 30, 2023
FAIR MARKET MEASUREMENTS [Abstract]
FAIR MARKET MEASUREMENTS	NOTE 9. - FAIR MARKET MEASUREMENTS The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of June 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. Description Level 1 Level 2 Level 3 Assets at June 30 2023 Investments held in Trust Account $ 16,510,676 $ — $ — Assets at December 31, 2022 Investments held in Trust Account $ 279,359,521 $ — $ — Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. There were no transfers between levels for the period from February 11, 2021 (inception) through June 30, 2023. Level 1 assets include investments in U.S. Treasury securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2023
SUBSEQUENT EVENTS [Abstract]
SUBSEQUENT EVENTS	NOTE 10. - SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred up to the date the financial statements were available to be issued. Based upon this review, the Company determined that there have been no events that have occurred that would require adjustments to the disclosures in the financial statements, except as described below: On July 5, 2023, the Company received written notice from the Listing Qualifications department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company was not in compliance with the continued listing requirement to maintain a minimum Market Value of Listed Securities (“MVLS”) of $50,000,000, as set forth in Nasdaq Listing Rule 5450(b)(2)(A). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company has a period of 180 calendar days, or until January 2, 2024, to regain compliance with the minimum MVLS requirement. To regain compliance, the Company’s MVLS must close at $50,000,000 or more for a minimum of ten consecutive business days during this 180 calendar day compliance period.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Jun. 30, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and Article 8 of Regulation S-X. Accordingly, certain disclosures included in the annual financial statements have been condensed or omitted from these financial statements as they are not required for interim financial statements . In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and six months ended June 30, 2023 are not necessarily The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC on April 5, 2023, which contains the audited financial statements and notes thereto.
Use of Estimates	Use of Estimates The preparation of condensed financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ from those estimates.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. As of June 30, 2023 and December 31, 2022, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of June 30, 2023 and December 31, 2022.
Investments Held in the Trust Account	Investments Held in the Trust Account The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in net gain from investments held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements,” approximates the carrying amounts represented in the balance sheets, primarily due to their short-term nature.
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Financial Instruments	Derivative Financial Instruments The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company accounted for its Rights (as defined below) as equity-classified instruments based on an assessment of the Rights’ specific terms and applicable authoritative guidance in ASC 480 and ASC 815. The assessment considered whether the Rights were freestanding financial instruments pursuant to ASC 480, met the definition of a liability pursuant to ASC 480, and whether the Rights met all the requirements for equity classification under ASC 815, including whether the Rights were indexed to the Company’s own ordinary shares, among other conditions for the equity classification. The warrants issued in connection with its Initial Public Offering (the “Public Warrants”) and Private Placement Warrants are classified in accordance with ASC 480 and ASC 815, which provides that the warrants are not precluded from equity classification. Equity-classified contracts were initially measured at fair value (or allocated value). Subsequent changes in fair value will not be recognized as long as the contracts continue to be classified in equity in accordance with ASC 480 and ASC 815.
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with Public Warrants are recognized net in equity. Offering costs associated with the Class A ordinary shares were charged against the carrying value of Class A ordinary shares upon the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, all outstanding Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets. Under ASC 480, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the Initial Public Offering, the Company recognized the remeasurement from initial book value to redemption amount value. The change in the carrying value of the redeemable Class A ordinary shares resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.
Net Income (Loss) per Ordinary Share	Net Income (Loss) per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is calculated by dividing the net income (loss) by the weighted average shares of ordinary shares outstanding for the respective period. The calculation of diluted net income (loss) per ordinary shares does not consider the effect of the Public Warrants, the Private Placement Warrants and the Rights to purchase an aggregate of 23,045,000 Class A ordinary shares since their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and six months ended June 30, 2023 and 2022. The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of ordinary shares: For the Three Months Ended June 30, For the Six Months Ended June 30, 2023 2022 2023 2022 Class A Class B Class A Class B Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share Numerator: Allocation of net income (loss) $ 1,032,849 $ 433,224 $ (250,091 ) $ (62,523 ) $ 3,265,697 $ 1,024,504 $ (506,353 ) $ (126,588 ) Denominator: Basic and diluted weighted average ordinary shares outstanding 16,450,307 6,900,000 27,600,000 6,900,000 21,994,353 6,900,000 27,600,000 6,900,000 Basic and diluted net income (loss) per ordinary share $ 0.06 $ 0.06 $ (0.01 ) $ (0.01 ) $ 0.15 $ 0.15 $ (0.02 ) $ (0.02 )
Income Taxes	Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Recent Accounting Standards	Recent Accounting Standards In June 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-13 – Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13” Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended
	Jun. 30, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Basic and Diluted Net Income (Loss) Per Share of Ordinary Share	The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of ordinary shares: For the Three Months Ended June 30, For the Six Months Ended June 30, 2023 2022 2023 2022 Class A Class B Class A Class B Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share Numerator: Allocation of net income (loss) $ 1,032,849 $ 433,224 $ (250,091 ) $ (62,523 ) $ 3,265,697 $ 1,024,504 $ (506,353 ) $ (126,588 ) Denominator: Basic and diluted weighted average ordinary shares outstanding 16,450,307 6,900,000 27,600,000 6,900,000 21,994,353 6,900,000 27,600,000 6,900,000 Basic and diluted net income (loss) per ordinary share $ 0.06 $ 0.06 $ (0.01 ) $ (0.01 ) $ 0.15 $ 0.15 $ (0.02 ) $ (0.02 )

CLASS A ORDINARY SHARES SUBJE_2

CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION (Tables)	6 Months Ended
	Jun. 30, 2023
CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION [Abstract]
Class A Ordinary Shares Subject to Possible Redemption	The Class A ordinary shares subject to possible redemption are reflected in the following table: Gross proceeds $ 276,000,000 Less: Proceeds allocated to Public Warrants and Rights (7,624,500 ) Class A ordinary shares issuance costs (15,877,541 ) Plus: Adjust carrying value to initial redemption value 26,761,562 Class A ordinary shares subject to possible redemption, December 31, 2022 279,259,521 Plus: Remeasurement on Class A ordinary shares subject to possible redemption 3,072,101 Class A ordinary shares subject to possible redemption, March 31, 2023 282,331,622 Less: Redemptions (267,753,501 ) Plus: Remeasurement on Class A ordinary shares subject to possible redemption 1,901,202 Class A ordinary shares subject to possible redemption, June 30, 2023 $ 16,479,323

FAIR MARKET MEASUREMENTS (Table

FAIR MARKET MEASUREMENTS (Tables)	6 Months Ended
	Jun. 30, 2023
FAIR MARKET MEASUREMENTS [Abstract]
Assets Measured at Fair Value on Recurring Basis	The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of June 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. Description Level 1 Level 2 Level 3 Assets at June 30 2023 Investments held in Trust Account $ 16,510,676 $ — $ — Assets at December 31, 2022 Investments held in Trust Account $ 279,359,521 $ — $ —

DESCRIPTION OF ORGANIZATION A_2

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS, Summary (Details)				3 Months Ended	6 Months Ended		12 Months Ended
	May 19, 2023 Extension	May 17, 2023 USD ($) $ / shares shares	Nov. 22, 2021 USD ($) $ / shares shares	Jun. 30, 2023 USD ($) $ / shares	Jun. 30, 2023 USD ($) Business $ / shares	Jun. 30, 2022 USD ($)	Dec. 31, 2022 USD ($) $ / shares
Description of Organization and Business Operations [Abstract]
Gross proceeds from initial public offering			$ 276,000,000
Deferred underwriting commissions			9,700,000	$ 9,660,000	$ 9,660,000		$ 9,660,000
Cash deposited in trust account			$ 276,000,000
Cash deposited in trust account per unit (in dollars per share) | $ / shares			$ 10
Percentage of public shares that can be redeemed without prior consent					15%
Percentage of public shares that would not be redeemed if business combination is not completed within initial combination period					100%
Number of extensions to extend time to consummate a business combination | Extension	6
Period of time of extension to consummate business combination	1 month
Period of advance notice to consummate initial business combination	5 days
Period of additional articles extension date	9 months
Redemption of ordinary shares					$ 267,753,501	$ 0
Period to redeem public shares if business combination is not completed within initial combination period					10 days
Class A Ordinary Shares [Member]
Description of Organization and Business Operations [Abstract]
Number of ordinary shares redeemed (in shares) | shares		26,015,981
Redemption price (in dollars per share) | $ / shares		$ 10.29		$ 10.4	$ 10.4		$ 10.12
Redemption of ordinary shares		$ 267,800,000
Minimum [Member]
Description of Organization and Business Operations [Abstract]
Number of operating businesses included in initial business combination | Business					1
Fair market value as percentage of net assets held in trust account included in initial business combination					80%
Post-transaction ownership percentage of the target business					50%
Net tangible assets threshold for redeeming public shares				$ 5,000,001	$ 5,000,001
Maximum [Member]
Description of Organization and Business Operations [Abstract]
Interest from trust account that can be held to pay dissolution expenses			$ 100,000
Initial Public Offering [Member]
Description of Organization and Business Operations [Abstract]
Units issued (in shares) | shares			27,600,000
Share price (in dollars per share) | $ / shares			$ 10
Gross proceeds from initial public offering			$ 276,000,000				$ 276,000,000
Offering costs			16,300,000
Deferred underwriting commissions			$ 9,700,000
Redemption of ordinary shares				$ 267,753,501
Over-Allotment Option [Member]
Description of Organization and Business Operations [Abstract]
Units issued (in shares) | shares			3,600,000
Share price (in dollars per share) | $ / shares			$ 10
Private Placement [Member] | Private Placement Warrants [Member]
Description of Organization and Business Operations [Abstract]
Share price (in dollars per share) | $ / shares			$ 1
Warrants issued (in shares) | shares			7,520,000
Gross proceeds from private placement			$ 7,500,000

DESCRIPTION OF ORGANIZATION A_3

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS, Liquidity and Going Concern (Details) - USD ($)					1 Months Ended		3 Months Ended	6 Months Ended
	Apr. 01, 2022	Nov. 24, 2021	Nov. 22, 2021	Feb. 12, 2021	Mar. 31, 2023	Jul. 31, 2022	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Mar. 31, 2022
Liquidity and Capital Resources [Abstract]
Cash							$ 32,548	$ 32,548		$ 60,591
Working capital							120,000	120,000
Loan proceeds								474,480	$ 0
Loan repayment		$ 1,000
Notes payable							$ 774,480	$ 774,480		$ 300,000
Notes Payable, Noncurrent, Related Party, Type [Extensible Enumeration]							Sponsor [Member]	Sponsor [Member]		Sponsor [Member]
Private Placement Warrants [Member]
Liquidity and Capital Resources [Abstract]
Notes payable							$ 774,000	$ 774,000		$ 300,000
Promissory Note [Member] | Initial Public Offering [Member]
Liquidity and Capital Resources [Abstract]
Loan repayment			$ 166,000
Sponsor [Member]
Liquidity and Capital Resources [Abstract]
Contribution from sale of founder shares							$ 25,000
Sponsor [Member] | Promissory Note [Member]
Liquidity and Capital Resources [Abstract]
Loan proceeds			167,000
Loan repayment		$ 1,000
Sponsor [Member] | Promissory Note [Member] | Maximum [Member]
Liquidity and Capital Resources [Abstract]
Related party transaction				$ 300,000
Sponsor [Member] | Promissory Note [Member] | Initial Public Offering [Member]
Liquidity and Capital Resources [Abstract]
Loan repayment			$ 166,000
Sponsor [Member] | Convertible Promissory Note [Member]
Liquidity and Capital Resources [Abstract]
Period to complete Business Combination after closing of Initial Public Offering							18 months	18 months
Conversion price (in dollars per share)											$ 1
Loan proceeds					$ 474,000	$ 300,000
Sponsor [Member] | Convertible Promissory Note [Member] | Maximum [Member]
Liquidity and Capital Resources [Abstract]
Related party transaction	$ 1,500,000						$ 726,000
Sponsor [Member] | Convertible Promissory Note [Member] | Private Placement Warrants [Member] | Maximum [Member]
Liquidity and Capital Resources [Abstract]
Related party transaction	$ 1,500,000				$ 474,000		$ 1,500,000

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Cash and Cash Equivalents (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Cash and Cash Equivalents [Abstract]
Cash equivalents	$ 0	$ 0

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Net Income (Loss) Per Ordinary Share (Details)	3 Months Ended		6 Months Ended
	Jun. 30, 2023 USD ($) $ / shares shares	Jun. 30, 2022 USD ($) $ / shares shares	Jun. 30, 2023 USD ($) Class $ / shares shares	Jun. 30, 2022 USD ($) $ / shares shares
Net income (loss) Per Ordinary Share [Abstract]
Number of share classes reported | Class			2
Warrant [Member]
Net income (loss) Per Ordinary Share [Abstract]
Antidilutive securities excluded from computation of earnings per share (in shares)			23,045,000
Class A Ordinary Shares [Member]
Numerator [Abstract]
Allocation of net income (loss) | $	$ 1,032,849	$ (250,091)	$ 3,265,697	$ (506,353)
Denominator [Abstract]
Basic weighted average ordinary shares outstanding (in shares)	16,450,307	27,600,000	21,994,353	27,600,000
Diluted weighted average ordinary shares outstanding (in shares)	16,450,307	27,600,000	21,994,353	27,600,000
Basic net income (loss) per ordinary share (in dollars per share) | $ / shares	$ 0.06	$ (0.01)	$ 0.15	$ (0.02)
Diluted net income (loss) per ordinary share (in dollars per share) | $ / shares	$ 0.06	$ (0.01)	$ 0.15	$ (0.02)
Class B Ordinary Shares [Member]
Numerator [Abstract]
Allocation of net income (loss) | $	$ 433,224	$ (62,523)	$ 1,024,504	$ (126,588)
Denominator [Abstract]
Basic weighted average ordinary shares outstanding (in shares)	6,900,000	6,900,000	6,900,000	6,900,000
Diluted weighted average ordinary shares outstanding (in shares)	6,900,000	6,900,000	6,900,000	6,900,000
Basic net income (loss) per ordinary share (in dollars per share) | $ / shares	$ 0.06	$ (0.01)	$ 0.15	$ (0.02)
Diluted net income (loss) per ordinary share (in dollars per share) | $ / shares	$ 0.06	$ (0.01)	$ 0.15	$ (0.02)

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Income Taxes (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Income Taxes [Abstract]
Unrecognized tax benefits	$ 0	$ 0
Accrued interest and penalties	$ 0	$ 0

INITIAL PUBLIC OFFERING (Detail

INITIAL PUBLIC OFFERING (Details) - USD ($)		12 Months Ended
	Nov. 22, 2021	Dec. 31, 2022	Jun. 30, 2023
Initial Public Offering [Abstract]
Gross proceeds from initial public offering	$ 276,000,000
Deferred underwriting commissions	$ 9,700,000	$ 9,660,000	$ 9,660,000
Exercise price of warrant (in dollars per share)			$ 11.5
Rights [Member]
Initial Public Offering [Abstract]
Number of shares issued upon exercise of warrant (in shares)		0.062	0.062
Initial Public Offering [Member]
Initial Public Offering [Abstract]
Units issued (in shares)	27,600,000
Share price (in dollars per share)	$ 10
Gross proceeds from initial public offering	$ 276,000,000	$ 276,000,000
Offering costs	16,300,000
Deferred underwriting commissions	$ 9,700,000
Initial Public Offering [Member] | Public Warrants [Member]
Initial Public Offering [Abstract]
Number of securities included in each Unit (in shares)			0.50
Exercise price of warrant (in dollars per share)			$ 11.5
Initial Public Offering [Member] | Class A Ordinary Shares [Member]
Initial Public Offering [Abstract]
Number of securities included in each Unit (in shares)			1
Number of shares issued upon exercise of warrant (in shares)			1
Initial Public Offering [Member] | Rights [Member]
Initial Public Offering [Abstract]
Number of securities included in each Unit (in shares)			1
Number of shares issued upon exercise of warrant (in shares)			0.062
Over-Allotment Option [Member]
Initial Public Offering [Abstract]
Units issued (in shares)	3,600,000
Share price (in dollars per share)	$ 10

PRIVATE PLACEMENT (Details)

PRIVATE PLACEMENT (Details) - USD ($) $ / shares in Units, $ in Millions		6 Months Ended
	Nov. 22, 2021	Jun. 30, 2023
Private Placement [Abstract]
Exercise price of warrant (in dollars per share)		$ 11.5
Private Placement [Member]
Private Placement [Abstract]
Holding period for transfer, assignment or sale of warrants		30 days
Private Placement [Member] | Private Placement Warrants [Member]
Private Placement [Abstract]
Warrants issued (in shares)	7,520,000
Share price (in dollars per share)	$ 1
Gross proceeds from issuance of warrants	$ 7.5
Private Placement [Member] | Private Placement Warrants [Member] | Class A Ordinary Shares [Member]
Private Placement [Abstract]
Number of shares issued upon exercise of warrant (in shares)		1
Exercise price of warrant (in dollars per share)		$ 11.5

RELATED PARTY TRANSACTIONS, Fou

RELATED PARTY TRANSACTIONS, Founder Shares (Details)			1 Months Ended	3 Months Ended	6 Months Ended
	Oct. 25, 2021 shares	Feb. 12, 2021 USD ($) shares	May 31, 2021 shares	Jun. 30, 2023 USD ($) $ / shares shares	Jun. 30, 2023 Director $ / shares shares	Dec. 31, 2022 shares	Nov. 22, 2021 shares	Nov. 17, 2021 shares
Founder Shares [Abstract]
Number of independent directors nominees | Director					2
Class A Ordinary Shares [Member]
Founder Shares [Abstract]
Ordinary shares, shares outstanding (in shares)				0	0	0
Threshold trading days					20 days
Threshold consecutive trading days					30 days
Class A Ordinary Shares [Member] | Minimum [Member]
Founder Shares [Abstract]
Share price (in dollars per share) | $ / shares				$ 12	$ 12
Period after initial Business Combination					150 days
Class B Ordinary Shares [Member]
Founder Shares [Abstract]
Ordinary shares, shares outstanding (in shares)				6,900,000	6,900,000	6,900,000
Sponsor [Member]
Founder Shares [Abstract]
Proceeds from issuance of common stock | $				$ 25,000
Sponsor [Member] | Class A Ordinary Shares [Member]
Founder Shares [Abstract]
Percentage of founder shares held by sponsor considered as unvested shares					25%
Number of shares considered to be newly unvested in first share price level (in shares)					0.50
Percentage of founder shares held by sponsor considered as vested shares					12.50%
Trigger price of first share (in dollars per share) | $ / shares				$ 12.5	$ 12.5
Threshold trading days of first share price level					20 days
Threshold consecutive trading days of first share price level					30 days
Number of shares considered to be newly unvested In second share price level (in shares)					0.50
Percentage of founder shares held by sponsor considered as vested shares in Second Share Price Level					12.50%
Trigger price of second share (in dollars per share) | $ / shares				$ 15	$ 15
Threshold trading days of second share price level					20 days
Threshold consecutive trading days of second share price level					30 days
Sponsor [Member] | Class B Ordinary Shares [Member]
Founder Shares [Abstract]
Issuance of Class B ordinary shares to Sponsor (in shares)		8,625,000
Proceeds from issuance of common stock | $		$ 25,000
Number of shares surrender (in shares)	2,875,000
Ordinary shares, shares outstanding (in shares)								6,900,000
Founder shares as percentage of issued and outstanding shares after Initial Public Offering							20%
Ordinary shares no longer subject to forfeiture (in shares)							900,000
Holding period for transfer, assignment or sale of founder shares					1 year
Sponsor [Member] | Class B Ordinary Shares [Member] | Maximum [Member]
Founder Shares [Abstract]
Number of shares subject to forfeiture (in shares)		900,000		900,000	900,000
Director Nominee One [Member]
Founder Shares [Abstract]
Issuance of Class B ordinary shares to Sponsor (in shares)			40,000
Director Nominee Two [Member]
Founder Shares [Abstract]
Issuance of Class B ordinary shares to Sponsor (in shares)			40,000

RELATED PARTY TRANSACTIONS, Rel

RELATED PARTY TRANSACTIONS, Related Party Loans (Details) - USD ($)					1 Months Ended		3 Months Ended	6 Months Ended
	Apr. 01, 2022	Nov. 24, 2021	Nov. 22, 2021	Feb. 12, 2021	Mar. 31, 2023	Jul. 31, 2022	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Mar. 31, 2022
Related Party Loans [Abstract]
Proceeds from related party transaction								$ 474,480	$ 0
Loan repayment		$ 1,000
Convertible working capital loan - related party							$ 774,480	$ 774,480		$ 300,000
Notes Payable, Noncurrent, Related Party, Type [Extensible Enumeration]							Sponsor [Member]	Sponsor [Member]		Sponsor [Member]
Private Placement Warrants [Member]
Related Party Loans [Abstract]
Convertible working capital loan - related party							$ 774,000	$ 774,000		$ 300,000
Promissory Note [Member] | Initial Public Offering [Member]
Related Party Loans [Abstract]
Loan repayment			$ 166,000
Sponsor [Member] | Promissory Note [Member]
Related Party Loans [Abstract]
Proceeds from related party transaction			167,000
Loan repayment		$ 1,000
Sponsor [Member] | Promissory Note [Member] | Maximum [Member]
Related Party Loans [Abstract]
Related party transaction				$ 300,000
Sponsor [Member] | Promissory Note [Member] | Initial Public Offering [Member]
Related Party Loans [Abstract]
Loan repayment			$ 166,000
Sponsor [Member] | Convertible Promissory Note [Member]
Related Party Loans [Abstract]
Proceeds from related party transaction					$ 474,000	$ 300,000
Conversion price (in dollars per share)											$ 1
Period to complete Business Combination after closing of Initial Public Offering							18 months	18 months
Sponsor [Member] | Convertible Promissory Note [Member] | Maximum [Member]
Related Party Loans [Abstract]
Related party transaction	$ 1,500,000						$ 726,000
Sponsor [Member] | Convertible Promissory Note [Member] | Private Placement Warrants [Member] | Maximum [Member]
Related Party Loans [Abstract]
Related party transaction	$ 1,500,000				$ 474,000		$ 1,500,000
Sponsor, Affiliate of Sponsor, or Certain Company Officers and Directors [Member] | Convertible Promissory Note [Member]
Related Party Loans [Abstract]
Loans that can be converted into Warrants at lenders' discretion								$ 1,500,000
Conversion price (in dollars per share)							$ 1	$ 1

RELATED PARTY TRANSACTIONS, Adm

RELATED PARTY TRANSACTIONS, Administrative Services Agreement (Details) - USD ($)		3 Months Ended		6 Months Ended
	Nov. 17, 2021	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Administrative Services Agreement [Abstract]
Accrued expenses		$ 74,697		$ 74,697		$ 6,187
Administrative Services Agreement [Member]
Administrative Services Agreement [Abstract]
Incurred expenses		30,000	$ 30,000	60,000	$ 60,000
Accrued expenses		$ 5,000		$ 5,000		$ 5,000
Sponsor [Member] | Administrative Services Agreement [Member]
Administrative Services Agreement [Abstract]
Monthly expenses	$ 10,000

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details)		1 Months Ended	6 Months Ended
	Nov. 22, 2021 USD ($) $ / shares shares	May 31, 2023 USD ($) Business $ / shares shares	Jun. 30, 2023 USD ($) Demand	Dec. 31, 2022 USD ($)	Nov. 17, 2021 shares
Underwriting Agreement [Abstract]
Term of option for underwriters to purchase additional Units to cover over-allotments			45 days
Additional Units that can be purchased to cover over-allotments (in shares) | shares					3,600,000
Underwriting discount (in dollars per share)	$ 0.2
Underwriting discount | $	$ 5,500,000
Deferred underwriting commissions per Unit (in dollars per share)	$ 0.35
Deferred underwriting commissions | $	$ 9,700,000		$ 9,660,000	$ 9,660,000
Non-Redemption Agreement [Member]
Underwriting Agreement [Abstract]
Ordinary shares subject to possible redemption (in shares) | shares		1,500,000
Number of shares to be issued by sponsor (in shares) | shares		375,000
Contribution - shareholder non-redemption agreements | $		$ 363,750
Share price (in dollars per share)		$ 0.97
Probability of a business combination | Business		9.98
Non-Redemption Agreement [Member] | Volatility [Member]
Underwriting Agreement [Abstract]
Probability of a business combination | Business		26.2
Non-Redemption Agreement [Member] | Lack of Marketability Discount [Member]
Underwriting Agreement [Abstract]
Probability of a business combination | Business		6.5
Non-Redemption Agreement [Member] | Share Price [Member]
Underwriting Agreement [Abstract]
Share price (in dollars per share)		$ 10.42
Over-Allotment Option [Member]
Underwriting Agreement [Abstract]
Units issued (in shares) | shares	3,600,000
Share price (in dollars per share)	$ 10
Maximum [Member]
Registration Rights [Abstract]
Number of demands entitled to holders | Demand			3

CLASS A ORDINARY SHARES SUBJE_3

CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION (Details)			3 Months Ended		6 Months Ended		12 Months Ended
	May 17, 2023 USD ($)	Nov. 22, 2021 USD ($)	Jun. 30, 2023 USD ($) $ / shares shares	Mar. 31, 2023 USD ($)	Jun. 30, 2023 USD ($) Vote $ / shares shares	Jun. 30, 2022 USD ($)	Dec. 31, 2022 USD ($) $ / shares shares
Common Stock Subject To Possible Redemption [Abstract]
Gross proceeds		$ 276,000,000
Redemptions					$ (267,753,501)	$ 0
Class A Ordinary Shares [Member]
Common Stock Subject To Possible Redemption [Abstract]
Ordinary shares, shares authorized (in shares) | shares			500,000,000		500,000,000
Ordinary shares, par value (in dollars per share) | $ / shares			$ 0.0001		$ 0.0001		$ 0.0001
Voting rights per share | Vote					1
Ordinary shares, outstanding, subject to possible redemption (in shares) | shares			1,584,019		1,584,019		27,600,000
Redemptions	$ (267,800,000)
Class A ordinary shares subject to possible redemption			$ 16,479,323		$ 16,479,323		$ 279,259,521
Initial Public Offering [Member]
Common Stock Subject To Possible Redemption [Abstract]
Gross proceeds		$ 276,000,000					276,000,000
Redemptions			(267,753,501)
Remeasurement on Class A ordinary shares subject to possible redemption amount							26,761,562
Initial Public Offering [Member] | Class A Ordinary Shares [Member]
Common Stock Subject To Possible Redemption [Abstract]
Class A ordinary shares issuance costs							(15,877,541)
Remeasurement on Class A ordinary shares subject to possible redemption amount			1,901,202	$ 3,072,101
Class A ordinary shares subject to possible redemption			$ 16,479,323	$ 282,331,622	$ 16,479,323		279,259,521
Initial Public Offering [Member] | Public Warrants and Rights [Member]
Common Stock Subject To Possible Redemption [Abstract]
Proceeds allocated to Public Warrants and Rights							$ (7,624,500)

SHAREHOLDERS' DEFICIT, Preferen

SHAREHOLDERS' DEFICIT, Preference and Ordinary Shares (Details)	6 Months Ended
	Jun. 30, 2023 Vote $ / shares shares	Dec. 31, 2022 $ / shares shares	Nov. 17, 2021 shares	Feb. 12, 2021 shares
Shareholders' Deficit [Abstract]
Preference shares, shares authorized (in shares)	5,000,000	5,000,000
Preference shares, par value (in dollars per share) | $ / shares	$ 0.0001	$ 0.0001
Preference shares, shares issued (in shares)	0	0
Preference shares, shares outstanding (in shares)	0	0
Stock conversion percentage threshold	20%
As-converted percentage for Class A ordinary shares after conversion of Class B shares	20%
Stock conversion basis of Class B to Class A ordinary shares at time of initial Business Combination	1
Class A Ordinary Shares [Member]
Shareholders' Deficit [Abstract]
Ordinary shares,, shares authorized (in shares)	500,000,000	500,000,000
Ordinary shares, par value (in dollars per share) | $ / shares	$ 0.0001	$ 0.0001
Ordinary shares, outstanding, subject to possible redemption, issued (in shares)	1,584,019	27,600,000
Ordinary shares, outstanding, subject to possible redemption, outstanding (in shares)	1,584,019	27,600,000
Ordinary shares, shares issued (in shares)	0	0
Ordinary shares, shares outstanding (in shares)	0	0
Voting rights per share | Vote	1
Class B Ordinary Shares [Member]
Shareholders' Deficit [Abstract]
Ordinary shares,, shares authorized (in shares)	50,000,000	50,000,000
Ordinary shares, par value (in dollars per share) | $ / shares	$ 0.0001	$ 0.0001
Ordinary shares, shares issued (in shares)	6,900,000	6,900,000
Ordinary shares, shares outstanding (in shares)	6,900,000	6,900,000
Voting rights per share | Vote	1
Sponsor [Member] | Class B Ordinary Shares [Member]
Shareholders' Deficit [Abstract]
Ordinary shares, shares outstanding (in shares)			6,900,000
Sponsor [Member] | Class B Ordinary Shares [Member] | Maximum [Member]
Shareholders' Deficit [Abstract]
Shares subject to forfeiture (in shares)	900,000			900,000

SHAREHOLDERS' DEFICIT, Rights (

SHAREHOLDERS' DEFICIT, Rights (Details) - Rights [Member] - shares	Jun. 30, 2023	Dec. 31, 2022
Rights [Abstract]
Rights outstanding (in shares)	27,600,000	27,587,477
Number of shares issued upon exercise of warrant (in shares)	0.062	0.062

SHAREHOLDERS' DEFICIT, Warrants

SHAREHOLDERS' DEFICIT, Warrants (Details) - $ / shares	6 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Warrants [Abstract]
Period to exercise warrants after Business Combination	30 days
Period to file registration statement after initial Business Combination	20 days
Period for registration statement to become effective	60 days
Exercise price of warrant (in dollars per share)	$ 11.5
Expiration period of warrants	5 years
Public Warrants [Member]
Warrants [Abstract]
Warrants outstanding (in shares)	13,800,000	13,800,000
Percentage multiplier	180%
Warrant redemption price (in dollars per share)	$ 0.01
Notice period to redeem warrants	30 days
Threshold trading days	10 days
Threshold consecutive trading days	20 days
Number of trading days ending before notice of redemption	3 days
Number of shares issued upon exercise of warrant (in shares)	0.361
Private Placement Warrants [Member]
Warrants [Abstract]
Warrants outstanding (in shares)	7,520,000	7,520,000
Period of warrants not transferable, assignable or salable	30 days
Class A Ordinary Shares [Member]
Warrants [Abstract]
Threshold trading days	20 days
Threshold consecutive trading days	30 days
Class A Ordinary Shares [Member] | Minimum [Member]
Warrants [Abstract]
Share price (in dollars per share)	$ 12
Class A Ordinary Shares [Member] | Public Warrants [Member]
Warrants [Abstract]
Share price (in dollars per share)	$ 18
Additional Issue of Common Stock or Equity-Linked Securities [Member]
Warrants [Abstract]
Percentage multiplier	115%
Threshold trigger price for redemption of warrants (in dollars per share)	$ 18
Additional Issue of Common Stock or Equity-Linked Securities [Member] | Minimum [Member]
Warrants [Abstract]
Aggregate gross proceeds from issuance as a percentage of total equity proceeds	60%
Additional Issue of Common Stock or Equity-Linked Securities [Member] | Class A Ordinary Shares [Member]
Warrants [Abstract]
Trading days prior to notice of redemption to the warrant holders	20 days
Additional Issue of Common Stock or Equity-Linked Securities [Member] | Class A Ordinary Shares [Member] | Maximum [Member]
Warrants [Abstract]
Share price (in dollars per share)	$ 9.2

FAIR MARKET MEASUREMENTS (Detai

FAIR MARKET MEASUREMENTS (Details) - USD ($)	29 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Transfers to/from Fair Value Hierarchy Levels [Abstract]
Transfers into Level 3	$ 0
Transfers out of Level 3	0
Recurring [Member] | Level 1 [Member]
Assets [Abstract]
Investments held in Trust Account	16,510,676	$ 279,359,521
Recurring [Member] | Level 2 [Member]
Assets [Abstract]
Investments held in Trust Account	0	0
Recurring [Member] | Level 3 [Member]
Assets [Abstract]
Investments held in Trust Account	$ 0	$ 0